Jagar Jasem, MD, MPH
Assistant Professor, Medicine-Hematology

Graduate School :
  • MPH, University of Nebraska Medical Center (2012)
  • Ohio State University Hospital Program (2014)
  • University of Colorado, Internal Medicine (2016)
  • Johns Hopkins University School of Medicine Program, Hematology (2020)
Languages: English, Arabic, Kurdish
Department: Medicine-Hematology

Recognition & Awards

  • Fullbright Scholarship, U.S. Department of State (2010)
  • "Top Medical Student" Honor Diploma, Ministry of Higher Education, Iraq (2008)

Research Interests

My research interests involve evaluating the health outcomes of patients with lymphoma and other hematological malignancies; including assessing survivorship patterns, quality of care delivered, disparities in care, and the economic burden of cancer care delivery.


  • Haverkos B, Zain J, Kamdar M, Neuwelt A, Davila E, Bradeen X, Major A, Bair S, Jasem J, Smith C, Abbott D, Porcu P. Frontline chemoimmunotherapy with nivolumab and dose-adjusted EPOCH in peripheral T-cell lymphoma: a phase 1 trial. Blood Adv. 2024 Feb 13;8(3):708-711. PubMed PMID: 38150586
  • Bahouth MN, Kraus P, Dane K, Plazas Montana M, Tsao W, Tabaac B, Jasem J, Schmidlin H, Einstein E, Streiff MB, Shanbhag S. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticides: Observational case series and management recommendations. Medicine (Baltimore). 2019 Sep;98(36):e17015. PubMed PMID: 31490385
  • Hambley BC, Norsworthy KJ, Jasem J, Zimmerman JW, Shenderov E, Webster JA, Showel MM, Gondek LP, Dalton WB, Prince G, Gladstone DE, Streiff MB, Pratz KW, Gojo I, Ghiaur G, Levis MJ, Smith BD, DeZern AE. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction. Leuk Res. 2019 Aug;83:106174. PubMed PMID: 31255938
  • Iyer P, Jasem J, Springer MA, Klein CE, Kabos P. PALB2-Positive Breast Cancer in a 40-Year-Old Man. Oncology (Williston Park). 2017 Jan 15;31(1):50-2, 54. PubMed PMID: 28090623
  • Jasem J, Fisher CM, Amini A, Shagisultanova E, Rabinovitch R, Borges VF, Elias A, Kabos P. The 21-Gene Recurrence Score Assay for Node-Positive, Early-Stage Breast Cancer and Impact of RxPONDER Trial on Chemotherapy Decision-Making: Have Clinicians Already Decided?. J Natl Compr Canc Netw. 2017 Apr;15(4):494-503. PubMed PMID: 28404760
  • Amini A, Jasem J, Jones BL, Robin TP, McDermott JD, Bhatia S, Raben D, Jimeno A, Bowles DW, Karam SD. Predictors of overall survival in human papillomavirus-associated oropharyngeal cancer using the National Cancer Data Base. Oral Oncol. 2016 May;56:1-7. PubMed PMID: 27086480
  • Jasem J, Amini A, Rabinovitch R, Borges VF, Elias A, Fisher CM, Kabos P. 21-Gene Recurrence Score Assay As a Predictor of Adjuvant Chemotherapy Administration for Early-Stage Breast Cancer: An Analysis of Use, Therapeutic Implications, and Disparity Profile. J Clin Oncol. 2016 Jun 10;34(17):1995-2002. PubMed PMID: 27001563
  • Jasem J, Altoos B, Fisher CM, Elias AD, Kounalakis N, Borges VF, Kabos P. Multiple Hepatic Lesions in a Patient With a History of DCIS. Oncology (Williston Park). 2015 Sep;29(9):669-70, 678-9. PubMed PMID: 26384804
  • Bhatt VR, Balasetti V, Jasem JA, Giri S, Armitage JO, Loberiza FR Jr, Bociek RG, Bierman PJ, Maness LJ, Vose JM, Fayad P, Akhtari M. Central Nervous System Complications and Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation. Clin Lymphoma Myeloma Leuk. 2015 Oct;15(10):606-11. PubMed PMID: 26184063
View All (9 Total) View Less

Professional Memberships

  • American Society of Hematology, Member
  • American Society of Clinical Oncology, Member
  • Society of General Internal Medicine, Member
  • American Public Health Association, Member
  • American Medical Informatics Association (AMIA), Member

Practice Locations

UCHealth Blood Disorders and Cell Therapies Center - Anschutz Medical Campus
1665 Aurora Court
3rd floor, Anschutz Cancer Pavilion
Aurora, CO 80045

UCHealth Anschutz Inpatient Pavilion - Anschutz Medical Campus
12605 E. 16th Ave
Aurora, CO 80045

CU Medicine Medical Oncology - Highlands Ranch Specialty Care Center
1500 Park Central Drive
Suite 101
Highlands Ranch, CO 80129

Hospital Affiliation
  • UCHealth Highlands Ranch Hospital
  • University of Colorado Hospital
Center Affiliations

Specialty Information

  • Internal Medicine, Board Certification
  • Hematology, Board Certification
Conditions & Treatments
  • Blood / Lymphatic System
  • Cancers - Lymphoma
  • Cancers
Care Philosophy
I believe in providing optimal care for lymphoma patients, that is based on an integration of research-based evidence, clinical competence, and the patient values and preferences.

Personal Interests
Following completion of medical school in Kurdistan Region of Iraq, Dr. Jasem came to the United States as a Fulbright Scholar and pursued a master's degree in public health/epidemiology at the University of Nebraska Medical Center. Meanwhile, he re-qualified his medical degree and conducted research, both locally and internationally, involving the health needs assessment of the underserved and refugee populations. He later pursued an internship in internal medicine at The Ohio State University, residency in internal medicine at the University of Colorado, and fellowship in hematology at Johns Hopkins University. In his free time, Dr. Jasem enjoys hiking, soccer, listening to classic oriental music; and translating and publishing history, political, and scientific books from English to Arabic and Kurdish.

Public Speaking

General Information

Graduate Schools:
  • MPH, University of Nebraska Medical Center (2012)
  • Ohio State University Hospital Program (2014)
Residency Programs:
  • University of Colorado, Internal Medicine (2016)
  • Johns Hopkins University School of Medicine Program, Hematology (2020)
Languages: English, Arabic, Kurdish
Department: Medicine-Hematology
Contact Us
CU Anschutz
Fitzsimons Building

13001 East 17th Place
Campus Box C290
Aurora, CO 80045

Update My Profile